alendronate has been researched along with Diabetes Mellitus, Type 1 in 3 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Alendronate was also able to reduce marrow adiposity in both control diabetic mice compared to untreated mice." | 1.42 | Bisphosphonate treatment of type I diabetic mice prevents early bone loss but accentuates suppression of bone formation. ( Baumann, MJ; Coe, LM; McCabe, LR; Shu, Y; Tekalur, SA, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mostafavinia, A | 1 |
| Ahadi, R | 1 |
| Abdollahifar, M | 1 |
| Ghorishi, SK | 1 |
| Jalalifirouzkouhi, A | 1 |
| Bayat, M | 1 |
| Coe, LM | 1 |
| Tekalur, SA | 1 |
| Shu, Y | 1 |
| Baumann, MJ | 1 |
| McCabe, LR | 1 |
| Vestergaard, P | 1 |
3 other studies available for alendronate and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Evaluation of the Effects of Photobiomodulation on Biomechanical Properties and Hounsfield Unit of Partial Osteotomy Healing in an Experimental Rat Model of Type I Diabetes and Osteoporosis.
Topics: Alendronate; Animals; Biomechanical Phenomena; Blood Glucose; Diabetes Mellitus, Type 1; Disease Mod | 2017 |
Bisphosphonate treatment of type I diabetic mice prevents early bone loss but accentuates suppression of bone formation.
Topics: Alendronate; Animals; Bone Density; Bone Density Conservation Agents; Bone Resorption; Diabetes Mell | 2015 |
Risk of newly diagnosed type 2 diabetes is reduced in users of alendronate.
Topics: Age of Onset; Aged; Aged, 80 and over; Alendronate; Bone Density Conservation Agents; Case-Control S | 2011 |